Co-developed by Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY), Dupixent has bagged the U.S. Food and Drug Administration’s approval to treat eosinophilic...
The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi’s (NASDAQ: SNY) lead drug candidate Dupixent® (dupilumab) 300 mg...
A French court has ordered Sanofi SA (NASDAQ: SNY) to pay more than €400,000 in damages to a French family whose child had autism caused by its epilepsy drug Valproate.The court...
Protalix's PRX-102 drug stands a good chance of being accepted against Fabry disease, with three P3 trials delivering good results.
Traders await US economic data to justify strongest monthly stock advance in 3 decadesOil rebound slowsBitcoin close to all-time highKey EventsThe most powerful global, monthly...
European equities opened firmer again on Thursday morning, extending gains from a very strong session on Wall Street. France’s CAC led the way after President Macron announced an...
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Strong Sell | Sell | Buy | Strong Buy |
| Technical Indicators | Buy | Strong Buy | Strong Sell | Strong Buy | Strong Buy |
| Summary | Neutral | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 180.80 | 182.30 | 179.70 | +0.80 | +0.44% | 828.96K | London | |||
| 228.00 | 228.00 | 223.00 | +6.00 | +2.70% | 96.87K | London | |||
| 227.50 | 227.00 | 227.00 | +1.50 | +0.67% | 38.09K | London | |||
| 160.80 | 163.20 | 159.00 | -0.60 | -0.37% | 548.83K | London | |||
| 794.80 | 798.60 | 742.00 | +49.00 | +6.57% | 4.53M | London | |||
| 241.00 | 241.00 | 232.60 | +7.00 | +2.99% | 919.68K | London | |||
| 3.80 | 4.68 | 3.80 | -0.470 | -11.01% | 2.69M | London | |||
| 625.00 | 629.00 | 607.00 | -8.00 | -1.26% | 33.25K | London | |||
| 901.40 | 902.40 | 843.00 | +43.00 | +5.01% | 3.91M | London | |||
| 48.80 | 53.20 | 47.70 | -4.20 | -7.92% | 4.14M | London | |||
| 3.05 | 2.95 | 2.95 | +0.10 | +3.39% | 1.22M | London | |||
| 710.00 | 715.00 | 700.00 | 0.00 | 0.00% | 23.20K | London | |||
| 227.20 | 229.40 | 223.70 | +3.70 | +1.66% | 12.97M | London | |||
| 151.10 | 152.50 | 150.98 | +0.10 | +0.07% | 70.25K | London | |||
| 321.60 | 328.40 | 315.60 | -2.50 | -0.77% | 420.01K | London |